Open AccessComparative effectiveness of incretin-based therapies and the risk of death and cardiovascular events in 38,233 metformin monotherapy users
Author(s) -
JohnMichael Gamble,
Jamie M. Thomas,
Laurie Twells,
William K. Midodzi,
Sumit R. Majumdar
Publication year - 2016
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000003995
Subject(s) - medicine , metformin , mace , dipeptidyl peptidase 4 inhibitor , discontinuation , hazard ratio , glycated hemoglobin , cohort , incretin , proportional hazards model , retrospective cohort study , diabetes mellitus , type 2 diabetes , insulin , endocrinology , percutaneous coronary intervention , myocardial infarction , confidence interval
Supplemental Digital Content is available in the text